Table 5 Primary and secondary outcomes of AR-Centre and AR-Home participants after 20 training sessions (ITT Analysis)

FMA-UE^†

36.95±19.87

39.29±20.28

2.34±3.98

36.12±20.80

38.16±20.26

2.04±4.57

1.480 (− 1.677

0.760

(Max. 66)

(0.00003**)

(0.035*)

to 2.275)

FMA-LE^†

20.32±6.39

21.95±6.14

1.63±4.85

16.52±8.39

18.36±9.31

1.84±3.45

2.320 (− 2.343

0.843

(Max. 34)

(0.0005**)

(0.013*)

to 1.917)

BBS^†

43.00±11.97

44.14±11.58

1.13±3.69

40.20±8.74

42.08±5.79

1.88±5.09

0.192 (− 2.716

0.452

(Max. 56)

(0.022*)

(0.077)

to 1.221)

FAC^†

4.76±1.02

4.85±1.00

0.08±0.60

4.52±1.12

4.78±1.21

0.26±0.83

− 0.14 (− 0.495

0.122

(Max. 6)

(0.317)

(0.114)

to 0.144)

BI^†

N/A

N/A

N/A

16.72±2.54

17.60±2.40

0.88±1.13

N/A

N/A

(Max. 20)

(0.0007**)

SF-12v2 PCS^†

31.93±11.36

34.58±10.34

2.66±7.74

32.67±8.23

35.98±8.57

3.31±6.95

2.090 (− 4.217

0.718

(Max. 100)

(0.011*)

(0.026*)

to 2.918)

SF-12v2 MCS^†

42.14±19.34

45.63±15.05

3.49± 12.76

46.00±12.29

46.99±9.70

0.99±7.14

8.044 (− 2.910

0.360

(Max. 100)

(0.040*)

(0.495)

to 7.919)